Refractory Thrombocytopenia and Neutropenia: a Diagnostic Challenge

por Gyan, Emmanuel, Dreyfus, François, Fenaux, Pierre
Publicado 2015

How I Treat TP53-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

por Loschi, Michael, Fenaux, Pierre, Cluzeau, Thomas
Publicado 2022

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia

por Rahmé, Ramy, Braun, Thorsten, Manfredi, James J., Fenaux, Pierre
Publicado 2023

A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS

por Giagounidis, Aristoteles, Leto di Priolo, Susanna, Ille, Susanne, Fenaux, Pierre
Publicado 2011

Strongyloidiasis in Man 75 Years after Initial Exposure

por Prendki, Virginie, Fenaux, Pierre, Durand, Rémy, Thellier, Marc, Bouchaud, Olivier
Publicado 2011

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia

por Cluzeau, Thomas, Loschi, Michael, Fenaux, Pierre, Komrokji, Rami, Sallman, David A.
Publicado 2021

Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

por Giagounidis, Aristoteles, Mufti, Ghulam J., Fenaux, Pierre, Germing, Ulrich, List, Alan, MacBeth, Kyle J.
Publicado 2013

Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta‐analysis

por Park, Sophie, Fenaux, Pierre, Greenberg, Peter, Mehta, Bhakti, Callaghan, Fiona, Kim, Christopher, Tomita, Dianne, Xu, Hairong
Publicado 2016

Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory

por Zhu, Jaja, Lemaire, Pierre, Mathis, Stéphanie, Ronez, Emily, Clauser, Sylvain, Jondeau, Katayoun, Fenaux, Pierre, Adès, Lionel, Bardet, Valérie
Publicado 2022

Yeast Assay Highlights the Intrinsic Genomic Instability of Human PML Intron 6 over Intron 3 and the Role of Replication Fork Proteins

por Chanet, Roland, Kienda, Guy, Heneman-Masurel, Amélie, Vernis, Laurence, Cassinat, Bruno, Guardiola, Philippe, Fenaux, Pierre, Chomienne, Christine, Huang, Meng-Er
Publicado 2015

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long‐term safety and efficacy

por Fenaux, Pierre, Muus, Petra, Kantarjian, Hagop, Lyons, Roger M., Larson, Richard A., Sekeres, Mikkael A., Becker, Pamela S., Orejudos, Amelia, Franklin, Janet
Publicado 2017

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

por Giagounidis, Aristoteles, Fenaux, Pierre, Mufti, Ghulam J., Muus, Petra, Platzbecker, Uwe, Sanz, Guillermo, Cripe, Larry, Von Lilienfeld-Toal, Marie, Wells, Richard A.
Publicado 2008

PB2014: A PHASE 2/3 TRIAL OF ORAL AZACITIDINE IN PATIENTS WITH LOW- OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROMES

por Garcia-Manero, Guillermo, Santini, Valeria, Fenaux, Pierre, Suzuki, Takahiro, Sekeres, Mikkael, He, Jun, Barkalifa, Ronit, Vigil, Carlos, Prebet, Thomas, Komrokji, Rami S., Giagounidis, Aristoteles
Publicado 2023

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)

por Bello, Erica, Pellagatti, Andrea, Shaw, Jacqueline, Mecucci, Cristina, Kušec, Rajko, Killick, Sally, Giagounidis, Aristoteles, Raynaud, Sophie, Calasanz, María J., Fenaux, Pierre, Boultwood, Jacqueline
Publicado 2015

Arsenic Trioxide Treatment during Pregnancy for Acute Promyelocytic Leukemia in a 22-Year-Old Woman

por Cochet, Claire, Simonet, Marion, Cattin, Julie, Metz, Jean-Patrick, Berceanu, Ana, Deconinck, Eric, Daguindau, Etienne, Schillinger, Françoise, Fenaux, Pierre, Mottet, Nicolas, Desbrosses, Yohan
Publicado 2020

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis

por Tarfi, Sihem, Harrivel, Véronique, Dumezy, Florent, Guy, Julien, Roussel, Mikael, Mimoun, Aguirre, Fenaux, Pierre, Chapuis, Nicolas, Solary, Eric, Selimoglu-Buet, Dorothée, Wagner-Ballon, Orianne
Publicado 2018

Next‐generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data f...

por Ramos, Pedro Marques, Choi, Jeea, Campbell, Catarina D., Wang, Ying A., Pallaud, Celine, Dickinson, Michael, Verma, Amit, Mittelman, Moshe, Platzbecker, Uwe, Cherif, Honar, Fenaux, Pierre
Publicado 2023

Valuation of transfusion-free living in MDS: results of health utility interviews with patients

por Szende, Agota, Schaefer, Caroline, Goss, Thomas F, Heptinstall, Kathy, Knight, Robert, Lübbert, Michael, Deschler, Barbara, Fenaux, Pierre, Mufti, Ghulam J, Killick, Sally, List, Alan F
Publicado 2009

Prognostic impact of JAK2V617F mutation in myelodysplatic syndromes: A matched case control study()

por de Renzis, Benoit, Mansat-De Mas, Veronique, Wattel, Eric, Beyne-Rauzy, Odile, Knoops, Laurent, Cabrespine, Aurélie, Azgui, Zahia, Ades, Lionel, Kiladjian, Jean-Jacques, Fenaux, Pierre
Publicado 2013

Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

por Prebet, Thomas, Toma, Andrea, Cluzeau, Thomas, Sekeres, Mikkael A., Vey, Norbert, Park, Sophie, Al Ali, Najla, Sugrue, Marie M., Komrokji, Rami, Fenaux, Pierre, Gore, Steven D.
Publicado 2017